Literature DB >> 17255538

Low plasma RANTES levels are an independent predictor of cardiac mortality in patients referred for coronary angiography.

Erdal Cavusoglu1, Calvin Eng, Vineet Chopra, Luther T Clark, David J Pinsky, Jonathan D Marmur.   

Abstract

OBJECTIVE: Our objective was to evaluate the prognostic value of baseline plasma RANTES levels in patients with known or suspected coronary artery disease. RANTES is a chemokine produced by a variety of cell types including platelets that has been implicated in atherosclerosis. METHODS AND
RESULTS: Baseline plasma RANTES levels were measured in 389 male patients undergoing coronary angiography at a Veterans Affairs Medical Center. The patients were followed-up prospectively for the occurrence of cardiac mortality and myocardial infarction. Follow-up data at 24 months were available for 97% of patients. In the entire cohort of patients, low baseline RANTES levels were an independent predictor of cardiac mortality. For cardiac death at 24 months, the survival rate was 87.3% in the lowest tertile of RANTES values, compared with 94% in the upper 2 tertiles combined (P=0.0298 by log rank test). Furthermore, when patients were risk-stratified into those with and without an acute coronary syndrome, RANTES was an independent predictor of both cardiac mortality and myocardial infarction in those without an acute coronary syndrome. Finally, RANTES was also an independent predictor of cardiac mortality in the diabetic subset.
CONCLUSIONS: In a cohort of male patients undergoing coronary angiography, low baseline plasma RANTES levels are an independent predictor of cardiac mortality.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255538     DOI: 10.1161/01.ATV.0000258789.21585.76

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  25 in total

1.  Association of circulating levels of RANTES and -403G/A promoter polymorphism to acute heart failure after STEMI and to cardiogenic shock.

Authors:  Jolana Lipkova; Jiri Parenica; Kamil Duris; Katerina Helanova; Josef Tomandl; Lenka Kubkova; Anna Vasku; Monika Goldbergova Pavkova
Journal:  Clin Exp Med       Date:  2014-06-17       Impact factor: 3.984

2.  Serum profiles of monocyte chemoattractant protein-1 as a biomarker for patients recovering from myocardial infarction.

Authors:  Katarzyna Korybalska; Małgorzata Pyda; Stefan Grajek; Magdalena Lanocha; Andrzej Breborowicz; Janusz Witowski
Journal:  Clin Res Cardiol       Date:  2010-02-07       Impact factor: 5.460

3.  Intensive lifestyle modification reduces Lp-PLA2 in dyslipidemic HIV/HAART patients.

Authors:  Joshua S Wooten; Preethi Nambi; Baiba K Gillard; Henry J Pownall; Ivonne Coraza; Lynne W Scott; Vijay Nambi; Christie M Ballantyne; Ashok Balasubramanyam
Journal:  Med Sci Sports Exerc       Date:  2013-06       Impact factor: 5.411

4.  Effects of alpha 1-antitrypsin on endotoxin-induced lung inflammation in vivo.

Authors:  Devipriya Subramaniyam; Chad Steele; Thomas Köhnlein; Tobias Welte; Olof Grip; Sadis Matalon; Sabina Janciauskiene
Journal:  Inflamm Res       Date:  2010-03-18       Impact factor: 4.575

5.  The inflammatory preatherosclerotic remodeling induced by intermittent hypoxia is attenuated by RANTES/CCL5 inhibition.

Authors:  Claire Arnaud; Pauline C Beguin; Sylvie Lantuejoul; Jean-Louis Pepin; Christiane Guillermet; Graziano Pelli; Fabienne Burger; Vanessa Buatois; Christophe Ribuot; Jean-Philippe Baguet; François Mach; Patrick Levy; Maurice Dematteis
Journal:  Am J Respir Crit Care Med       Date:  2011-06-16       Impact factor: 21.405

Review 6.  Chemokine receptor CCR5: from AIDS to atherosclerosis.

Authors:  K L Jones; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

7.  Assessment of genetic diversity in IL-6 and RANTES promoters and their level in Saudi coronary artery disease patients.

Authors:  Nasimudeen R Jabir; Chelapram K Firoz; Mohammad A Kamal; Ghazi A Damanhouri; Mohammed Nabil Alama; Anas S Alzahrani; Hussein A Almehdar; Shams Tabrez
Journal:  J Clin Lab Anal       Date:  2016-11-09       Impact factor: 2.352

8.  Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study.

Authors:  Salim S Virani; Vijay Nambi; Ron Hoogeveen; Bruce A Wasserman; Josef Coresh; Franklyn Gonzalez; Lloyd E Chambless; Thomas H Mosley; Eric Boerwinkle; Christie M Ballantyne
Journal:  Eur Heart J       Date:  2010-10-12       Impact factor: 29.983

9.  Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy.

Authors:  John Doupis; Thomas E Lyons; Szuhuei Wu; Charalambos Gnardellis; Thanh Dinh; Aristidis Veves
Journal:  J Clin Endocrinol Metab       Date:  2009-03-10       Impact factor: 5.958

10.  Chemokine RANTES is increased at early stages of coronary artery disease.

Authors:  J Podolec; G Kopec; L Niewiara; M Komar; B Guzik; K Bartus; L Tomkiewicz-Pajak; T J Guzik; W Plazak; K Zmudka
Journal:  J Physiol Pharmacol       Date:  2016-04       Impact factor: 3.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.